Trial intelligence / Profile preview

Preoperative sildenafil before mitral valve replacement in patients with pulmonary hypertension

PACTR201703002106114Recruiting

Sponsor
Menoufia University
Start
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Trial of sildenafil in pulmonary hypertension (PH) and mitral valve disease (3 arms), sponsored by Menoufia University. Primary endpoint: Effect of oral sildenafil on lowering pulmonary hypertension preoperative. Started Apr 2017; status: recruiting.

02

Drugs

sildenafil
03

Conditions

pulmonary hypertension (PH)mitral valve disease

Beyond the preview

Go deeper on PACTR201703002106114.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201703002106114.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call